| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tscan Therapeutics, Inc. (TCRX) has 12 insiders with recent SEC Form 4 filings, including 15 buys and 1 sell. TCRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.02M | $9.70M | - | |
| CEO | 1.17M | $1.41M | - | |
| Other | 420.0K | $508.2K | - | |
| Other | 350.0K | $423.5K | - | |
| CFO | 350.0K | $423.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Lynx1 Capital Management LP45 | 10% Owner | Buy | 161,801 | $0.90 | $145,525.97 | +0.7% | +14.2% | - | |
| May 20, 2025 | Lynx1 Capital Management LP45 | 10% Owner | Buy | 2,588,794 | $1.20 | $3,106,552.80 | +21.4% | +47.9% | - | |
| Dec 13, 2024 | Lynx1 Capital Management LP45 | 10% Owner | Buy | 131,800 | $2.93 | $385,768.96 | +1.3% | -37.2% | -64.6% | |
| Nov 15, 2024 | Lynx1 Capital Management LP45 | 10% Owner | Buy | 947 | $4.34 | $4,113.96 | - | -53.7% | -75.1% | |
| Sep 23, 2024 | Klencke Barbara | Director | Buy | 5,000 | $5.29 | $26,450.00 | +12.5% | -42.1% | -65.4% | |
| Aug 26, 2024 | Klencke Barbara | Director | Buy | 10,000 | $5.61 | $56,100.00 | +15.4% | -20.3% | -66.7% | |
| Aug 23, 2024 | Zdraveski Zoran | See Remarks | Sale+OE | 164,686 | $5.78 | $952,115.64 | -97.2% | -30.5% | -67.0% | |
| Dec 19, 2023 | Barberich Timothy J56 | Director | Buy | 29,147 | $4.89 | $142,455.69 | +27.9% | +39.4% | -40.8% | |
| Dec 14, 2023 | Klencke Barbara | Director | Buy | 5,000 | $5.08 | $25,400.00 | +20.0% | +34.2% | -43.0% | |
| Jun 2, 2023 | Barberich Timothy J56 | Director | Buy | 37,880 | $2.63 | $99,563.79 | New | -15.3% | +204.3% |